Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jaguar Health, Inc. - Common Stock (NQ:JAGX)

0.8601 -0.0134 (-1.53%)
Streaming Delayed Price Updated: 1:31 PM EDT, Aug 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Jaguar Health, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
News headline image
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Via ACCESSWIRE
News headline image
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present October 16 at BIO Investor Forum
Via ACCESSWIRE
News headline image
Jaguar Health Submits Abstract for First-of-Kind Study Evaluating the Impact of Diarrhea from Cancer Therapies in Breast Cancer Patients Who Received Placebo in its OnTarget Phase 3 Trial
Via ACCESSWIRE
News headline image
Jaguar Health Reports Statistically Significant Improvement in Breast Cancer Patients in its Phase 3 OnTarget Trial for its Cancer Supportive Care Drug Crofelemer
Via ACCESSWIRE
News headline image
Jaguar Health Scientific Advisory Board Member to Share Poster Presentation at American Society of Clinical Oncology (ASCO) Quality Care Symposium About the Methodologies Involved in Designing an Advocate-Led Quality of Life Survey for Cancer Patients and
Via ACCESSWIRE
News headline image
New Innovators with Jane King Interview with Jaguar Health CEO Lisa Conte Spotlights Company’s Near-Term Commercial & Development Milestones
Via ACCESSWIRE
News headline image
Patent Issued in Jordan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
Via ACCESSWIRE
News headline image
Issuance of New Hong Kong Patent Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
Via ACCESSWIRE
News headline image
Jaguar Health to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024
Via ACCESSWIRE
News headline image
Jaguar Health to Spotlight Company's Commercial Focus on Cancer Supportive Care at American Society for Radiation Oncology (ASTRO) Annual Meeting for FDA-Approved Gelclair Oral Mucositis Product in Advance of October 2024 Gelclair Launch
Via ACCESSWIRE
News headline image
Jaguar Health to Present September 19 at the MedInvest Biotech & Pharma Investor Conference
Via ACCESSWIRE
News headline image
Jaguar Health Appoints Industry Veteran to Head Sales for Company’s Commercialized Oncology and HIV Products Including October 2024 Launch of Gelclair for Cancer Supportive Care
Via ACCESSWIRE
News headline image
Jaguar Health to Present at the September 9-11 H.C. Wainwright Annual Global Investment Conference
Via ACCESSWIRE
News headline image
Jaguar Health Celebrates National Service Dog Month: With its Supportive Cancer Care Drugs, Jaguar is Dedicated to the Health and Wellbeing of People and Dogs
Via ACCESSWIRE
News headline image
Why Jaguar Health (JAGX) Stock Is Down 15% ↗
Jaguar Health shares are trading lower by 15.4% during Tuesday's session. The company reported worse-than-expected second-quarter results. 
Via Benzinga
News headline image
Jaguar Health Reports Second Quarter 2024 Financial Results
Via ACCESSWIRE
News headline image
Key Collaborator of Jaguar Health Joint Venture Magdalena Biosciences Receives Prestigious Alzheimer's Association Award
Via ACCESSWIRE
News headline image
JAGX Stock Earnings: Jaguar Health Misses EPS, Misses Revenue for Q2 2024 ↗
JAGX stock results show that Jaguar Health missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, August 13th at 8:30 AM Eastern to Review Q2 Earnings and Further Review Phase 3 OnTarget Trial’s Clinically Meaningful Results in Breast and Lung Cancer Patients
Via ACCESSWIRE
News headline image
Jaguar Health Issues Shareholder Letter: Company to Explore Approval Pathway for Crofelemer in Breast and Lung Cancer Based on Phase 3 Results - Investor Webcast August 13th Will Review Q2 Earnings and Further Review OnTarget Trial’s Clinically Meaningful
Via ACCESSWIRE
News headline image
Elaine Elisabetsky, PhD, Member of Jaguar Health's Mental Health Entheogen Therapeutics Initiative, to Speak August 2nd About Plant-Based Medicines Used to Manage Schizophrenia at the University of Illinois Chicago College of Pharmacy
Via ACCESSWIRE
News headline image
Issuance of New European Patent Bolsters IP Protection for Jaguar Health in the Treatment of Congenital Diarrheal Disorders (CDDs)
Via ACCESSWIRE
News headline image
Why Jaguar Health Stock Is Crashing ↗
Jaguar Health shares are falling Tuesday after the company announced its phase 3 OnTarget trial did not meet its primary endpoint. Here's a look at the details: 
Via Benzinga
News headline image
Two Investigator-Initiated Responder Analysis Trials of Jaguar Health's Crofelemer Show Significant Positive Results for Chronic Refractory Diarrhea in IBS-D: Data Accepted for Presentation at American College of Gastroenterology 2024 Annual Meeting
Via ACCESSWIRE
News headline image
Gold Moves Higher; Coca-Cola Increases FY24 Forecast ↗
 
Via Benzinga
News headline image
Why Is Azitra (AZTR) Stock Up 315% Today? ↗
Azitra stock is up on Tuesday alongside heavy trading of AZTR shares after it provided investors with an update on new patents. 
Via InvestorPlace
News headline image
Spot Ethereum ETFs: 9 Tickers to Watch as New Funds Start Trading ↗
Spot Ethereum ETFs have started trading on Tuesday marking a major milestone for fans of the crypto and Ethereum blockchain. 
Via InvestorPlace
Topics ETFs
News headline image
Why Is Serve Robotics (SERV) Stock Down Today? ↗
Serve Robotics stock is down on Tuesday after the company revealed the pricing of warrants for SERV shares in a private placement. 
Via InvestorPlace
News headline image
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Why Is Jaguar Health (JAGX) Stock Down 55% Today? ↗
Jaguar Health stock is down on Tuesday as JAGX investors react to failed results from a Phase 3 clinical trial of crofelemer. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.